-
-
-
-
-
-
-
Sarepta Therapeutics Announces Fourth Quarter and Full-Year 2022 Financial Results and Recent Corporate Developments
-
-
-
-
-
-
-
Sarepta Therapeutics Announces Third Quarter 2021 Financial Results and Recent Corporate Developments
-
-
-
-
-
-
-
Sarepta Therapeutics Announces First Quarter 2021 Financial Results and Recent Corporate Developments
-
-
-
-
-
-
-
Sarepta Therapeutics Announces Third Quarter 2020 Financial Results and Recent Corporate Developments
-
-
-
-
-
-
-
Sarepta Therapeutics (SRPT) Enters Partnership with Roche for SRP-9001 Outside the U.S.; Receives $1.15B Upfront
-
-
-
-
-
-
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Nektar Therapeutics, Valaris, Sarepta Therapeutics, and Canada Goose and Encourages Investors to Contac
-
-
-
-
-
-
-
Sarepta Therapeutics (SRPT) to Offer $350M in Common Stock
-
924,278 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All